Suchergebnisse - "SARS–CoV–2"

PubPharm (107.059)

1

Optimization of duplex digital PCR for the measurement of SARS-CoV-2 RNA

enthalten in: Journal of virological methods | 2024

von Lee, S. | Kim, A. | Park, J. | +2

2

Incidence and Mortality of COVID-19-Associated Invasive Fungal Infections Among Critically Ill Intubated Patients : A Multicenter Retrospective Cohort Analysis

enthalten in: Open forum infectious diseases | 2024

von Zuniga-Moya, J. | Papadopoulos, B. | Mansoor, A. | +3

3

Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults : A phase 3, randomized, active-controlled, multicenter trial

enthalten in: Vaccine | 2024

von Nurdin, A. | Movieta Nency, Y. | Maddeppungeng, M. | +24

4

Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial

enthalten in: Vaccine | 2024

von Baum, H. | Thirard, R. | Halliday, A. | +13

5

Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021

enthalten in: Vaccine | 2024

von Archer, H. | McCoy, S. | Sears, D. | +4

6

Update on Omicron variant and its threat to vulnerable populations

enthalten in: Public health in practice (Oxford, England) | 2024

von Dai, B. | Ji, W. | Zhu, P. | +3

7

The abortive SARS-CoV-2 infection of osteoclast precursors promotes their differentiation into osteoclasts

enthalten in: Journal of medical virology | 2024

von Sviercz, F. | Jarmoluk, P. | Godoy Coto, J. | +6

8

Genetic variants in ATP2B2 as risk factors for mortality in patients unrelated but not associated with families with severe COVID-19

enthalten in: Heliyon | 2024

von López-Bielma, M. | Falfán-Valencia, R. | Fierro-Piña, A. | +8

9

Temporal assessment of SARS-CoV-2 detection in wastewater and its epidemiological implications in COVID-19 case dynamics

enthalten in: Heliyon | 2024

von Li, L. | Haak, L. | Carine, M. | +1

10

Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation : An exploratory bi-centric cohort study

enthalten in: Thrombosis research | 2024

von Mayerhöfer, T. | Joannidis, M. | Peer, A. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[10706]